INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2017

B-vitamin supplements modestly reduced stroke risk but did not affect myocardial infarction or death.

An updated systematic review analyzed 15 randomized controlled trials with 71,422 participants evaluating vitamin B6, B9, or B12 supplements over 1 to 7.3 years. Compared to placebo, homocysteine-lowering interventions reduced stroke (4.3% vs. 5.1%; RR 0.90, 95% CI 0.82-0.99; 10 trials, n=44,224). However, no differences occurred for myocardial infarction (RR 1.02, 95% CI 0.95-1.10), all-cause mortality (RR 1.01, 95% CI 0.96-1.06), or serious adverse events (RR 1.07, 95% CI 1.00-1.14).

Study type
Systematic review and meta-analysis of randomized controlled trials
Who was studied
71,422 participants in 15 randomized controlled trials
What was measured
Stroke, myocardial infarction, all-cause mortality, and adverse events

THE PAPER

Homocysteine-lowering interventions for preventing cardiovascular events.

Martí-Carvajal AJ, Solà I, Lathyris D, Dayer M. Cochrane Database Syst Rev, 2017.

PubMed 28816346 ↗DOI 10.1002/14651858.CD006612.pub5 ↗

Heart & arteriesNutrients & adequacy

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.